TTR and cardiac amyloidosis: More than 98% of newly diagnosed cardiac amyloidosis is due to the deposition of fibrils composed of monoclonal immunoglobulin light chains (AL, OMIM 105200) or transthyretin (ATTR, OMIM 105210), either wild-type (ATTRwt) or mutated (ATTRm) [22].